Indivior PLC is a US-based specialty and generic drug manufacturin eneric drug manufacturg company. The firm develops, manufactures, and sells prescription drugs that are mainly based on buprenorphine for treatment of opioid dependence.
| Website: | www.indivior.com |
| Email: | www.investorcentre.co.uk/contactus |
| Main Phone: | +44 1753217800 |
| Address: | 103-105 Bath Road |
| State: | Berkshire |
| City / Town: | Slough |
| Country: | GBR |
| Postal Code: | SL1 3UH |
| Exchange: | OTO |
| CEO: | Shaun Thaxter |
| Employees: | 1023 |
| Last Price 2.55 | Change $ 0.05 | Change % 2.00 | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open 2.57 | High 2.57 | Low 2.55 | Prev Close 2.50 |
| Last Trade | Volume 1,309 | 52 Wk Hi 6.72 | 52 Wk Low 2.35 |
| Market Cap 1.9 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 728,306,837.00 | EPS (TTM) N/A | PE Ratio N/A | Exchange OTCPK |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 20FR12B/A | Amendment to a previously filed 20FR12B | 631 | 2016-08-24 |
| 20FR12B/A | Amendment to a previously filed 20FR12B | 674 | 2016-08-01 |
| 20FR12B | Registration of securities of foreign private issuers 12 (b) of the Securities Exchange Act | 242 | 2016-07-14 |
| EFFECT | Notice from the SEC of registration effectiveness | 1 | 2014-12-23 |
| F-6 | Registration of depository shares evidenced by American Depository Receipts | 45 | 2014-12-02 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
